US Stocks
/
Geron Corporation Share Price

Geron Corporation Share Price

NASDAQ: GERN | Small Cap
$1.23
+$0.01 (0.82%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Geron Corporation Stock Performance

Open
$1.22
Prev. Close
$1.22
Circuit Range
N/A
Day Range
$1.22 - $1.25
Year Range
$1.04 - $2.00
Volume
3,80,532
Average Traded
$1.22

Geron Corporation Share Price Today

As of 10 October 2026, Geron Corporation's share price is $1.23. The stock opened at $1.22, compared to its previous close of $1.22. During today's trading session, Geron Corporation's share price traded between $1.22 and $1.25, with an average price of $1.23. Over the past 52 weeks, the stock has recorded a high of $2.00 and a low of $1.04. In terms of performance, Geron Corporation's share price has declined by 20.71% over the last six months and is down 2.78% on a year-on-year basis.

Geron Corporation Share Price Chart

$1.22$1.25
L
Show Current Price
H

Geron Corporation Stock Fundamentals & Key Indicators

Market Cap
$816.66M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.11
Revenue (TTM)
$183.88B
Return On Equity (TTM)
-30.93%
Profit Margin
-45.41%
Debt to Equity
1.14
Quarterly Earnings Growth YoY
9.50%

Geron Corporation Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$47.23$48.02$51.84$57.48
Net Profit-$18.43-$28.86-$3.64-$16.68
Net Profit Margin-39.02%-60.10%-7.02%-29.02%
Income ChangeN/A-56.59%87.39%-358.24%

Geron Corporation Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.60$0.24$76.99$183.88
Net Profit-$141.90-$184.13-$174.57-$83.50
Net Profit Margin-23650.00%-76720.83%-226.74%-45.41%
Income ChangeN/A-29.76%5.19%52.17%

About Geron Corporation

Geron Corp is a biopharmaceutical company focused on blood cancers. Its telomerase inhibitor, RYTELO (imetelstat), is approved in the United States and European Union for certain adult patients with lower-risk myelodysplastic syndromes (LR-MDS) with transfusion-dependent anemia. RYTELO inhibits telomerase activity in malignant stem and progenitor cells, which may reduce abnormal cell proliferation while supporting the production of healthy cells. It is also conducting a Phase 3 trial of imetelstat in patients with JAK-inhibitor-refractory or relapsed myelofibrosis (R/R MF) and studies in other hematologic malignancies. The company operates as a single segment, being the development of therapeutic products for oncology.

Geron Corporation Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.24
$1.22
-1.21%
Sep 2026
$1.49
$1.24
-19.02%
Aug 2026
$1.27
$1.52
+17.76%
Jul 2026
$1.29
$1.29
+1.17%
Jun 2026
$1.25
$1.28
+3.23%
May 2026
$1.54
$1.24
-19.74%
Apr 2026
$1.52
$1.54
+4.04%
Mar 2026
$1.60
$1.49
-11.61%
Feb 2026
$1.35
$1.68
+23.53%
Jan 2026
$1.33
$1.36
+2.64%
Dec 2025
$1.16
$1.32
+12.29%
Nov 2025
$1.27
$1.18
-6.35%

GERN Share Price FAQs

What is Geron Corporation share price today?

chevron-up
Geron Corporation share price today is $1.23 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Geron Corporation stock?

chevron-up
The 52 week high of Geron Corporation stock is $2.00, while the 52 week low is $1.04 as of 10 Oct '26.

What is GERN's market capitalisation today?

chevron-up
GERN market capitalisation is $816.66M as of October 10, 2026, at 4:43 am IST.

What is GERN's net income for the last quarter?

chevron-up
GERN's net income for the last quarter is -16.68B USD.

What is the 5 year returns of GERN?

chevron-up
The 5 year returns of GERN is -20.45% as on 10 Oct '26.

What is the high & low stock price of GERN today?

chevron-up
GERN stock price hit a high of $1.25 and low of $1.22 as of 10 Oct '26.

Can I buy GERN shares in India?

chevron-up
Yes. You can buy GERN in India by opening an international trading account.